Skip to main content
Log in

A Critical Review of Current Worldwide Definitions of Sarcopenia

  • Review
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

With the increasing number of elderly individuals worldwide, the prevalence of age-related loss of muscle mass, referred to as sarcopenia, is expected to increase. Sarcopenia is a relatively new recognized syndrome, which is thought to affect 13% individuals worldwide, and the significant efforts made by different groups have advanced our understanding of the diagnosis, treatment, and natural history of this condition. However, the challenge is now to standardize its measurement and diagnosis to facilitate research in this area and a greater understanding of this condition and its management between clinicians and researchers. The Global Leadership Initiative on Sarcopenia (GLIS) is at the forefront of an international effort to produce standardized definition of sarcopenia. Setting a definition for sarcopenia entails several considerations and trade-offs. In this critical review, we have addressed key challenges driving the process of standardizing the definition, while delving into future avenues in sarcopenia research. Establishing a clear consensus on the working definition of sarcopenia is essential not only for advancing research in this field but also for assessing the prognostic implications of diagnosing sarcopenia and determining the most suitable treatment for affected patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rosenberg IH (1997) Sarcopenia: origins and clinical relevance. J Nutr 127(5):990S-991S

    Article  CAS  PubMed  Google Scholar 

  2. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR et al (1998) Epidemiology of Sarcopenia among the Elderly in New Mexico. Am J Epidemiol 147(8):755–763. https://doi.org/10.1093/oxfordjournals.aje.a009520

    Article  CAS  PubMed  Google Scholar 

  3. Janssen I, Heymsfield SB, Ross R (2002) Low relative skeletal muscle mass (Sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 50(5):889–896. https://doi.org/10.1046/j.1532-5415.2002.50216.x

    Article  PubMed  Google Scholar 

  4. Ligthart-Melis GC, Luiking YC, Kakourou A, Cederholm T, Maier AB, de Schueren MAE (2020) Frailty, sarcopenia, and malnutrition frequently (Co-)occur in hospitalized older adults: a systematic review and meta-analysis. J Am Med Dir Assoc 21(9):1216–1228

    Article  PubMed  Google Scholar 

  5. O’Shea E, Trawley S, Manning E, Barrett A, Browne V, Timmons S (2017) Malnutrition in hospitalised older adults: a multicentre observational study of prevalence, associations and outcomes. J Nutr Health Aging 21(7):830–836. https://doi.org/10.1007/s12603-016-0831-x

    Article  PubMed  Google Scholar 

  6. Sousa AS, Guerra RS, Fonseca I, Pichel F, Amaral TF (2016) Sarcopenia and length of hospital stay. Eur J Clin Nutr 70(5):595–601

    Article  CAS  PubMed  Google Scholar 

  7. Yang M, Hu X, Wang H, Zhang L, Hao Q, Dong B (2017) Sarcopenia predicts readmission and mortality in elderly patients in acute care wards: a prospective study. J Cachexia Sarcopenia Muscle 8(2):251–258. https://doi.org/10.1002/jcsm.12163

    Article  PubMed  Google Scholar 

  8. Beaudart C, Reginster JY, Amuthavalli Thiyagarajan J, Bautmans I, Bauer J, Burlet N et al (2023) Measuring health-related quality of life in sarcopenia: summary of the SarQoL psychometric properties. Aging Clin Exp Res 35(8):1581–1593. https://doi.org/10.1007/s40520-023-02438-3

    Article  PubMed  PubMed Central  Google Scholar 

  9. Yuan S, Larsson SC (2023) Epidemiology of sarcopenia: prevalence, risk factors, and consequences. Metabolism 144:155533

    Article  CAS  PubMed  Google Scholar 

  10. Papadopoulou SK, Tsintavis P, Potsaki G, Papandreou D (2020) Differences in the prevalence of sarcopenia in community-dwelling, nursing home and hospitalized individuals. A systematic review and meta-analysis. J Nutr Health Aging 24(1):83–90. https://doi.org/10.1007/s12603-019-1267-x

    Article  CAS  PubMed  Google Scholar 

  11. Vellas B, Fielding RA, Bens C, Bernabei R, Cawthon PM, Cederholm T et al (2018) Implications of ICD-10 for sarcopenia clinical practice and clinical trials: report by the international conference on frailty and sarcopenia research task force. J Frailty Aging 7(1):2–9

    CAS  PubMed  Google Scholar 

  12. Cruz-Jentoft AJ, Landi F, Schneider SM, Zúñiga C, Arai H, Boirie Y et al (2014) Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the international sarcopenia initiative (EWGSOP and IWGS). Age Ageing 43(6):748–759. https://doi.org/10.1093/ageing/afu115

    Article  PubMed  PubMed Central  Google Scholar 

  13. Senior HE, Henwood TR, Beller EM, Mitchell GK, Keogh JWL (2015) Prevalence and risk factors of sarcopenia among adults living in nursing homes. Maturitas 82(4):418–423

    Article  PubMed  Google Scholar 

  14. Coletta G, Phillips SM (2023) An elusive consensus definition of sarcopenia impedes research and clinical treatment: a narrative review. Ageing Res Rev 86:101883

    Article  PubMed  Google Scholar 

  15. Englund DA, Zhang X, Aversa Z, LeBrasseur NK (2021) Skeletal muscle aging, cellular senescence, and senotherapeutics: current knowledge and future directions. Mech Ageing Dev 200:111595

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Hwang J, Park S (2023) Gender-specific prevalence and risk factors of sarcopenic obesity in the Korean elderly population: a nationwide cross-sectional study. Int J Environ Res Public Health 20(2):1140

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Petermann-Rocha F, Balntzi V, Gray SR, Lara J, Ho FK, Pell JP et al (2022) Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 13(1):86–99. https://doi.org/10.1002/jcsm.12783

    Article  PubMed  Google Scholar 

  18. Bauer J, Morley JE, Schols AMWJ, Ferrucci L, Cruz-Jentoft AJ, Dent E et al (2019) Sarcopenia: a time for action an SCWD position paper. J Cachexia Sarcopenia Muscle 10(5):956–961. https://doi.org/10.1002/jcsm.12483

    Article  PubMed  PubMed Central  Google Scholar 

  19. Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K et al (2020) Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 21(3):300-307.e2

    Article  PubMed  Google Scholar 

  20. Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS et al (2014) Sarcopenia in Asia: consensus report of the Asian working group for sarcopenia. J Am Med Dir Assoc 15(2):95–101

    Article  PubMed  Google Scholar 

  21. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(1):16–31

    Article  PubMed  Google Scholar 

  22. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 39(4):412–423. https://doi.org/10.1093/ageing/afq034

    Article  PubMed  PubMed Central  Google Scholar 

  23. Daly RM, Iuliano S, Fyfe JJ, Scott D, Kirk B, Thompson MQ et al (2022) Screening, diagnosis and management of sarcopenia and frailty in hospitalized older adults: recommendations from the Australian and New Zealand society for sarcopenia and frailty research (ANZSSFR) expert working group. J Nutr Health Aging 26(6):637–651. https://doi.org/10.1007/s12603-022-1801-0

    Article  CAS  PubMed  Google Scholar 

  24. Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB et al (2011) Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12(4):249–256

    Article  PubMed  Google Scholar 

  25. Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB et al (2014) The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 69(5):547–558

    Article  PubMed  PubMed Central  Google Scholar 

  26. Muscaritoli M, Anker SD, Argilés J, Aversa Z, Bauer JM, Biolo G et al (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by special interest groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics.” Clin Nutr 29(2):154–159

    Article  CAS  PubMed  Google Scholar 

  27. Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE (2016) SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle 7(1):28–36

    Article  PubMed  Google Scholar 

  28. Roberts HC, Denison HJ, Martin HJ, Patel HP, Syddall H, Cooper C et al (2011) A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing 40(4):423–429. https://doi.org/10.1093/ageing/afr051

    Article  PubMed  Google Scholar 

  29. Bhasin S, Travison TG, Manini TM, Patel S, Pencina KM, Fielding RA et al (2020) Sarcopenia definition: the position statements of the sarcopenia definition and outcomes consortium. J Am Geriatr Soc 68(7):1410–1418. https://doi.org/10.1111/jgs.16372

    Article  PubMed  Google Scholar 

  30. Manini TM, Patel SM, Newman AB, Travison TG, Kiel DP, Shardell MD et al (2020) Identification of sarcopenia components that discriminate slow walking speed: a pooled data analysis. J Am Geriatr Soc 68(7):1419–1428

    Article  PubMed  PubMed Central  Google Scholar 

  31. Cawthon PM, Manini T, Patel SM, Newman A, Travison T, Kiel DP et al (2020) Putative cut-points in sarcopenia components and incident adverse health outcomes: an SDOC analysis. J Am Geriatr Soc 68(7):1429–1437. https://doi.org/10.1111/jgs.16517

    Article  PubMed  PubMed Central  Google Scholar 

  32. Westbury LD, Beaudart C, Bruyère O, Cauley JA, Cawthon P, Cruz-Jentoft AJ et al (2023) Recent sarcopenia definitions-prevalence, agreement and mortality associations among men: findings from population-based cohorts. J Cachexia Sarcopenia Muscle 14(1):565–575

    Article  PubMed  PubMed Central  Google Scholar 

  33. Rosas-Carrasco O, Cruz-Arenas E, Parra-Rodríguez L, García-González AI, Contreras-González LH, Szlejf C (2016) Cross-cultural adaptation and validation of the frail scale to assess frailty in mexican adults. J Am Med Dir Assoc 17(12):1094–1098

    Article  PubMed  Google Scholar 

  34. Coelho-Junior HJ, Marzetti E, Picca A, Calvani R, Cesari M, Uchida MC (2020) Prevalence of prefrailty and frailty in South America: a systematic review of observational studies. J Frailty Aging 9(4):197–213. https://doi.org/10.14283/jfa.2020.22

    Article  CAS  PubMed  Google Scholar 

  35. Akishita M, Kozaki K, Iijima K, Tanaka T, Shibasaki K, Ogawa S et al (2018) Chapter 1 definitions and diagnosis of sarcopenia. Geriatr Gerontol Int 18(S1):7–12. https://doi.org/10.1111/ggi.13311

    Article  PubMed  Google Scholar 

  36. Metanmo S, Kuate-Tegueu C, Gbessemehlan A, Dartigues JF, Ntsama MJ, Nguegang Yonta L et al (2022) Self-reported visual impairment and sarcopenia among older people in Cameroon. Sci Rep 12(1):17694

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Zengin A, Jarjou LM, Prentice A, Cooper C, Ebeling PR, Ward KA (2018) The prevalence of sarcopenia and relationships between muscle and bone in ageing West-African Gambian men and women. J Cachexia Sarcopenia Muscle 9(5):920–928

    Article  PubMed  PubMed Central  Google Scholar 

  38. Sayer AA, Cruz-Jentoft A (2022) Sarcopenia definition, diagnosis and treatment: consensus is growing. Age Ageing 51(10):220. https://doi.org/10.1093/ageing/afac220

    Article  Google Scholar 

  39. Cawthon PM, Visser M, Arai H, Ávila-Funes JA, Barazzoni R, Bhasin S et al (2022) Defining terms commonly used in sarcopenia research: a glossary proposed by the Global Leadership in Sarcopenia (GLIS) Steering Committee. Eur Geriatr Med 13(6):1239–1244

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

R.A.F. is partially supported by the US Department of Agriculture (USDA), under agreement No. 58-8050-9-004, by NIH Boston Claude D. Pepper Center (OAIC; 1P30AG031679), and by NIH University of Florida Claude D. Pepper Center (P30AG028740). Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the authors and do not necessarily reflect the view of the USDA.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Haya F. Alhmly.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alhmly, H.F., Fielding, R.A. A Critical Review of Current Worldwide Definitions of Sarcopenia. Calcif Tissue Int 114, 74–81 (2024). https://doi.org/10.1007/s00223-023-01163-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-023-01163-3

Keywords

Navigation